Abstract
Over the years there has been a considerable amount of controversy over whether the vascular component of migraine pain arises from the intracranial or the extracranial vessels, or both. Some have even questioned whether vasodilatation actually plays a significant role in migraine pain, and have described it as an unimportant epiphenomenon. The controversy is an artificial one though, which has been generated as a consequence of misrepresentation of the facts in the headache literature. In this review, some of the more blatant distortions in the literature are exposed.
Similar content being viewed by others
References
Andersen AR, Tfelt-Hansen P et al (1987) The effect of ergotamine and dihydroergotamine on cerebral blood flow in man. Stroke 18(1):120–123
Blau JN, Dexter SL (1981) The site of pain origin during migraine attacks. Cephalalgia 1(3):143–147
Brain SD, Williams TJ et al (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313(5997):54–56
Brazil P, Friedman AF (1955). Craniovascular studies: a report and analysis of pulse volume tracings in patients with headache. Trans Am Neurol Assoc 67–70 (80th Meeting)
Brennan KC, Charles A (2010) An update on the blood vessels in migraine. Curr Opin Neurol 23: Epub ahead of print
Burstein R, Yamamura H et al (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79(2):964–982
Burstein R, Yarnitsky D et al (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47(5):614–624
Cumberbatch MJ, Williamson DJ et al (1999) Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist. Br J Pharmacol 126(6):1478–1486
Doods H (2001) Development of CGRP antagonists for the treatment of migraine. Curr Opin Investig Drugs 2(9):1261–1268
Drummond PD, Lance JW (1981) Extracranial vascular reactivity in migraine and tension headache. Cephalalgia 1(3):149–155
Drummond PD, Lance JW (1983) Extracranial vascular changes and the source of pain in migraine headache. Ann Neurol 13(1):32–37
Dubner R (1991) Basic mechanisms of pain associated with deep tissues. Can J Physiol Pharmacol 69(5):607–609
Dubner R (1992) Hyperalgesia and expanded receptive fields. Pain 48(1):3–4
Durham PL (2006) Calcitonin gene-related peptide (CGRP) and migraine. Headache 46(Suppl 1):S3–S8
Edvinsson L, Goadsby PJ (1994) Neuropeptides in migraine and cluster headache. Cephalalgia 14(5):320–327
Edvinsson L, Tfelt-Hansen P (2008) The blood-brain barrier in migraine treatment. Cephalalgia 28(12):1245–1258
Elkind AH, Friedman AP et al (1964) Cutaneous Blood Flow in Vascular Headaches of the Migraine Type. Neurology 14:24–30
Farmer K (1995) Biofeedback and the treatment of headaches. In: Cady RK, Fox AW (eds) Treating the headache patient. Marcel Dekker, New York, pp 292–293
Goadsby PJ (2005) Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches. Drugs 65(18):2557–2567
Goadsby PJ (2006) Recent advances in the diagnosis and management of migraine. BMJ 332(7532):25–29
Goadsby PJ (2009a) Pathophysiology of migraine. Neurol Clin 27(2):335–360
Goadsby PJ (2009b) The vascular theory of migraine–a great story wrecked by the facts. Brain 132(Pt 1):6–7
Goadsby PJ, Bartsch T (2008) On the functional neuroanatomy of neck pain. Cephalalgia 28(Suppl 1):1–7
Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33(1):48–56
Goadsby PJ, Edvinsson L (1994) Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache 34(7):394–399
Goadsby PJ, Edvinsson L et al (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23(2):193–196
Goadsby PJ, Edvinsson L et al (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28(2):183–187
Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161(2):327–341
Gracely RH, Lynch SA et al (1992) Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 51(2):175–194
Graham JR, Wolff HG (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737–763
Hachinski V, Norris JW et al (1978) Ergotamine and cerebral blood flow. Stroke 9(6):594–596
Hoheisel U, Mense S (1989) Long-term changes in discharge behaviour of cat dorsal horn neurones following noxious stimulation of deep tissues. Pain 36(2):239–247
Iversen HK, Nielsen TH et al (1990) Arterial responses during migraine headache. Lancet 336(8719):837–839
Jansen I, Edvinsson L et al (1992) Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia 12(4):202–205
Juhasz G, Zsombok T et al (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25(3):179–183
Kaube H, Hoskin KL et al (1993) Inhibition by sumatriptan of central trigeminal neurones only after blood–brain barrier disruption. Br J Pharmacol 109(3):788–792
Lipton SA (1986) Prevention of classic migraine headache by digital massage of the superficial temporal arteries during visual aura. Ann Neurol 19(5):515–516
Lisspers J, Ost LG (1990) BVP-biofeedback in the treatment of migraine. The effects of constriction and dilatation during different phases of the migraine attack. Behav Modif 14(2):200–221
Louis S (1981) A bedside test for determining the sub-types of vascular headache. Headache 21(3):87–88
McCulloch J, Uddman R et al (1986) Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci USA 83(15):5731–5735
McMahon SB, Lewin GR et al (1993) Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 3(4):602–610
Mikkelsen E, Pedersen OL et al (1981) Effects of ergotamine on isolated human vessels. Arch Int Pharmacodyn Ther 252(2):241–252
Olesen J, Larsen B et al (1981) Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 9(4):344–352
Olesen J, Friberg L et al (1990) Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 28(6):791–798
Olesen IJ, Gulbenkian S et al (1995) The peptidergic innervation of the human superficial temporal artery: immunohistochemistry, ultrastructure, and vasomotility. Peptides 16(2):275–287
Olesen J, Diener HC et al (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350(11):1104–1110
Olesen J, Tfelt-Hansen P et al (2009) Finding new drug targets for the treatment of migraine attacks. Cephalalgia 29(9):909–920
Petersen KA, Birk S et al (2005a) The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 25(2):139–147
Petersen KA, Lassen LH et al (2005b) BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77(3):202–213
Pickering GW (1939) Experimental observations on headache. Br Med J 1:907–912
Russell MB, Olesen J (1995) Increased familial risk and evidence of genetic factor in migraine. BMJ 311(7004):541–544
Russell MB, Iselius L et al (1996) Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 16(5):305–309
Sakai F, Meyer JS (1978) Regional cerebral hemodynamics during migraine and cluster headaches measured by the 133Xe inhalation method. Headache 18(3):122–132
Sakai F, Meyer JS (1979) Abnormal cerebrovascular reactivity in patients with migraine and cluster headache. Headache 19(5):257–266
Schoonman GG, van der Grond J et al (2008) Migraine headache is not associated with cerebral or meningeal vasodilatation—a 3T magnetic resonance angiography study. Brain 131(Pt 8):2192–2200
Schumacher G, Wolff H (1941) Experimental studies on headache: A. Contrast of histamine headache with the headache of migraine and that associated with hypertension. B. Contrast of vascular mechanisms in pre-headache and in headache phenomena of migraine. Arch Neurol Psychiatry 45:199–214
Selby G, Lance JW (1960) Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 23:23–32
Shevel E (2007a) The Role of the External Carotid Vasculature in Migraine. In: Clarke LB (ed) Migraine Disorders Research Trends. Nova Science Publishers, New York
Shevel E (2007b) Vascular Surgery for Chronic Migraine. Therapy 4:451–456
Shevel E (2011) The extracranial vascular theory of migraine—a great story confirmed by the facts. Headache (accepted)
Shevel E, Spierings EH (2004) Role of the extracranial arteries in migraine headache: a review. Cranio 22(2):132–136
Stepien A, Jagustyn P et al (2003) Suppressing effect of the serotonin 5HT1B/D receptor agonist rizatriptan on calcitonin gene-related peptide (CGRP) concentration in migraine attacks. Neurol Neurochir Pol 37(5):1013–1023
Storer RJ, Akerman S et al (2004) Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 142(7):1171–1181
Strassman AM, Raymond SA et al (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384(6609):560–564
Sutherland AM, Wolff HG (1940) Experimental studies on headache: further analysis of the mechanism of headache in migraine, hypertension and fever. Arch Neurol Psychiatry 44:929–949
Tfelt-Hansen P, Le H (2009) Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review. J Headache Pain 10(3):137–143
Tunis MM, Wolff HG (1952) Analysis of cranial artery pulse waves in patients with vascular headache of the migraine type. Am J Med Sci 224(5):565–568
Tunis MM, Wolff HG (1953) Studies on headache; long-term observation of alterations in function of cranial arteries in subjects with vascular headache of the migraine type. Trans Am Neurol Assoc 3:121–123 78th Meeting
Tunis MM, Wolff HG (1954) Studies on headache; cranial artery vasoconstriction and muscle contraction headache. AMA Arch Neurol Psychiatry 71(4):425–434
Verheggen R, Bumann K et al (2002) BIBN4096BS is a potent competitive antagonist of the relaxant effects of alpha-CGRP on human temporal artery: comparison with CGRP (8–37). Br J Pharmacol 136(1):120–126
Vijayan N (1993) Head band for migraine headache relief. Headache 33(1):40–42
Wennerholm M (1961) Postural vascular reactions in cases of migraine and related vascular headaches. Acta Med Scand 169:131–139
Wolff HG (ed) (2001) Wolff’s Headache and Other Head Pain. Oxford University Press, New York
Wolff HG, Tunis MM et al (1953) Studies on headache: evidence of tissue damage and changes in pain sensitivity in subjects with vascular headaches of the migraine type. Trans Assoc Am Physicians 66:332–341
Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288(5472):1765–1769
Young WB, Rosen N et al (2007) Square one: headache education for the medical student. Headache 47(3):351–354
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shevel, E. The extracranial vascular theory of migraine: an artificial controversy. J Neural Transm 118, 525–530 (2011). https://doi.org/10.1007/s00702-010-0517-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-010-0517-1